相关实验视频
Updated: May 12, 2025

06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
6.2K
吸烟对MINOCA患者的影响
Hersh Osman1,2, Clara Schlettert3, Daniel Materzok3
1Department of Cellular and Translational Physiology, Institute of Physiology, Ruhr-University Bochum, Bochum, Germany.
European journal of clinical investigation
|May 9, 2025
概括
患有非阻塞性冠状动脉疾病 (MINOCA) 的心肌梗塞的吸烟患者长期表现比非吸烟者更好. 这种差异与吸烟组的并发病率较少和年龄较小有关,尽管在医院发生了类似的事件.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 心肌梗塞与非阻塞性冠状动脉疾病 (MINOCA) 的研究正在增长,但对吸烟患者的数据有限.
- 这项研究调查了有吸烟史的MINOCA患者的基线特征和住院结果.
研究的目的:
- 检查有吸烟史的MINOCA患者的住院并发症和基线特征.
- 为了比较MINOCA队列中当前吸烟者和非吸烟者之间的结果.
主要方法:
- 从2010年到2021年,对373名MINOCA患者 (85名吸烟者,283名非吸烟者) 的回顾性分析.
- 基于修改的"心肌梗塞第四普遍定义"标准的MINOCA诊断.
- 超过11年的住院事件和长期心血管结果的评估.
主要成果:
- 与非吸烟者相比,吸烟者心房动和糖尿病的发病率较低.
- 在吸烟者和非吸烟者之间,住院心血管事件和死亡率相似.
- 非吸烟者经历了更高的长期心血管事件发生率;年轻的吸烟者 (<50) 有了有利的结果.
结论:
- 与非吸烟者相比,使用MINOCA的吸烟者表现出优越的长期结果.
- 这种差异归因于非吸烟组中心血管并发症和年龄较高的患病率较高.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids
125
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
125
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K

